Operating Lease, Right-of-Use Asset of Cadrenal Therapeutics, Inc. from 31 Dec 2022 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cadrenal Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 30 Sep 2024.
  • Cadrenal Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2024 was $2,197, a 92% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cadrenal Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $2,197 -$24,698 -92% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $8,655 -$23,965 -73% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $14,920 -$23,260 -61% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $20,998 -$22,580 -52% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $26,895 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $32,620 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $38,180 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $43,578 31 Dec 2022 10-K 11 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.